TERN
Terns Pharmaceuticals, Inc. · Healthcare
Lav Biosciences Fund V, L.P. sold $8.3M of Terns Pharmaceuticals, Inc.
10% owner
Sold$8,250,000
$5.50Price
1,500,000Shares
−45%Stake
What TERN did after the filing
- The stock from Mon, Nov 28 close, $6.49
- +27.4%
- S&P 500, same days
- +0.4%
Measured over 30 trading days, to the Jan 11 close.
Traded Wed, Nov 23. Filed Mon, Nov 28, 11:56 AM ET, during the session. Returns use the Nov 28 close and the Jan 11 close. Not investment advice.